The composition of the Nomination Committee has been determined, Intervacc announced today that the Nomination Committee consists of the following persons who together represent approximately 16,6 percent of the number ... Read more
Legal Press releases
At the request of a group of shareholders which together control not less than one-tenth of all shares in Intervacc AB (publ), reg. no. 556238-1748 (the “Company”), the shareholders are hereby invited to an ... Read more
The Group in summary
Read moreStockholm, August 21, 2023 - The Board of Directors for Intervacc AB (publ) (”Intervacc”) has together with Andreas Andersson, made the decision that now is the right time for Andreas Andersson to leave his role as ... Read more
Stockholm, August 17, 2023 - Intervacc AB (publ) announces that it has been awarded an “industrial research” grant from Vinnova as part of a project with Testa Center, Uppsala, Sweden, to optimise the manufacturing ... Read more
Stockholm, July 11, 2023 - Intervacc AB (publ) announces the initiation of a project with Testa Center, Uppsala, to optimise the development of manufacturing processes for a prototype vaccine in pigs.